ELAN FY2025 SEC EDGAR DEF 14A #18 of 168 in industry

Elanco Animal Health Inc CEO pay ratio

The CEO earned $15.0M in FY2025 against median worker pay of $82,675 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
IN
Filing date
2026-04-08
Industry
Chemicals & Pharmaceuticals
Industry rank
#18/168

Data updated August 2026

Subscribe to Elanco Animal Health Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
181:1
High (Scale: 0–1000:1)
CEO pay
$15.0M
Median worker
$82,675

Answer first

Elanco Animal Health Inc's FY2025 CEO total of $15.0M ranks #309 of 1,423 complete filings; its 181:1 pay ratio ranks #351. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $82,675. Industry placement uses the FY2025 SIC-28 peer cohort (# 18 of 168, 90th percentile - top 10% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#309
$15.0M of 1,423 FY2025
Ratio rank
#351
181:1 of 1,423
Industry pct
90th
top 10% of industry peers by pay ratio

How Elanco Animal Health Inc ranks nationally

Elanco Animal Health Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$14,964,175 Top 22% higher than 78% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). This entry sits in this band. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Elanco Animal Health Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($15.0M) against pay ratio (181:1) for Elanco Animal Health Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6671929.313423760.420175591.526927422.633679253.634.5:175.8:1117:1158.3:1199.5:1CEO total payPay ratio (CEO : median worker)Elanco Animal Health Inc, CEO total pay: 14964175 · Pay ratio (CEO : median worker): 181:1Elanco Animal Health IncDuPont de Nemours, Inc., CEO total pay: 16157988 · Pay ratio (CEO : median worker): 189:1DuPont de Nemours, Inc.Cabot Corp, CEO total pay: 9307883 · Pay ratio (CEO : median worker): 171:1Cabot CorpFmc Corp, CEO total pay: 12025551 · Pay ratio (CEO : median worker): 191:1Fmc CorpAbbVie Inc., CEO total pay: 32451648 · Pay ratio (CEO : median worker): 192:1AbbVie Inc.Huntsman CORP, CEO total pay: 14649600 · Pay ratio (CEO : median worker): 168:1Huntsman CORP
Elanco Animal Health Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Elanco Animal Health Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Elanco Animal Health Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
181:1
FY2025
vs prior FY
0:1
from FY2024 181:1
CEO $ YoY
+1.1%
$15.0M latest
Filings shown
5
FY2021–2025
Elanco Animal Health Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $12.0M - $92,634 130:1 -
2022 $12.7M +5.5% $59,388 214:1 +84:1
2023 $13.7M +7.8% $67,459 203:1 -11:1
2024 $14.8M +8.1% $81,763 181:1 -22:1
2025 $15.0M +1.1% $82,675 181:1 0:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1739104, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
181:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$15.0M
Companies in Industry
168
vs. Industry Median
Above
#18 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Elanco Animal Health Inc: STEEP · HEAVY pay ratio

Elanco Animal Health Inc's FY2025 ratio 181:1 ranks #18 of 168 Chemicals & Pharmaceuticals filers (90th percentile). the CEO earned 181× the median employee ($82,675) in FY2025.

Median employee $82,675 (HIGH-MED); STEEP · HEAVY stamps put about 181 median-wage years per CEO year.

CEO Total Pay

$15.0M

FY2025 Summary Compensation, above median

Pay Ratio

181:1

Elevated vs. peers

Elanco Animal Health Inc in the higher Chemicals & Pharmaceuticals third

Elanco Animal Health Inc's FY2025 ratio 181:1 ranks #18 of 168 Chemicals & Pharmaceuticals filers (90th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Elanco Animal Health Inc's $15.0M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #309 and ratio rank #351 split - treat 181:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$15.0M
Median Employee Pay
$82,675
Pay Ratio
181:1
Filing Date
2026-04-08

Company Info

Ticker
ELAN
CIK
1739104
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
IN
View SEC filings →
SEC EDGAR DEF 14A for CIK 1739104, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Elanco Animal Health Inc's FY2025 ratio 181:1 ranks #18 of 168 Chemicals & Pharmaceuticals filers (90th percentile).

Read with Elanco Animal Health Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · HEAVY · HIGH-MED.

Nicolet Bankshares Inc · HEAVY

ABS(ceo_total_comp) peer at $15.0M (Δ $961 lighter vs Elanco Animal Health Inc); STEEP · PAR-MED vs this page's STEEP · HEAVY · HIGH-MED.
Astrana Health, Inc. · HEAVY

ABS(ceo_total_comp) peer at $15.0M (Δ $9K lighter vs Elanco Animal Health Inc); STEEP · PAR-MED vs this page's STEEP · HEAVY · HIGH-MED.
BridgeBio Pharma, Inc. · HEAVY

ABS(ceo_total_comp) peer at $14.9M (Δ $20K lighter vs Elanco Animal Health Inc); MODEST · ELITE-MED vs this page's STEEP · HEAVY · HIGH-MED.
Alnylam Pharmaceuticals, Inc. · HEAVY

ABS(ceo_total_comp) peer at $15.0M (Δ $20K heavier vs Elanco Animal Health Inc); MODEST · ELITE-MED vs this page's STEEP · HEAVY · HIGH-MED.
DuPont de Nemours, Inc. (SIC 28 pole)

DuPont de Nemours, Inc. stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Elanco Animal Health Inc's STEEP filing.
National dual ranks · #309/#351

Elanco Animal Health Inc's FY2025 package sits #309 by CEO dollars and #351 by ratio under HEAVY · STEEP.
Comp structure · HEAVY

Elanco Animal Health Inc's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Elanco Animal Health Inc (CIK 1739104), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.